Subscribe for the latest updates Email* Subscribe Thank you for subscribing! A confirmation email has been sent to your email address. Please follow the link to confirm your subscription Filter news by date Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year20192018201720162015201420132012201120102009200820072006 Apply International Dermatology Community Voting for the 2018 Galderma SKINPACT Awards Galderma Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis Women-Focused Biotech Takes Top Prize at Nestlé Skin Health SHIELD Pitch Event Galderma U.S. Initiates Six New Studies, Increasing Company's Commitment to Aesthetic Research and Innovation Experts call for improved identification of ‘High Burden’ rosacea patients in everyday practice Nestlé Skin Health and Maruho Release Renewed Itch Measurement App ‘Itch Tracker’ for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan Galderma Global Study Reveals True Burden Of Rosacea and Encourages Healthcare Professionals To Look ‘Beyond the Visible’ New Extended Deadline for the 2018 Galderma SKINPACT Awards – Focus on North America FDA Approval of Restylane® Lyft for Hands Nestlé invests CHF 150 million in two new factories Collaboration between Janssen’s and Galderma’s Nordic affiliates Nestlé Skin Health announces its intention to cease operations at its Egerkingen Factory Pagination Next page Next
Galderma Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
Galderma U.S. Initiates Six New Studies, Increasing Company's Commitment to Aesthetic Research and Innovation
Nestlé Skin Health and Maruho Release Renewed Itch Measurement App ‘Itch Tracker’ for Apple Watch on July 5, Maruho Receives Exclusive Rights in Japan
Galderma Global Study Reveals True Burden Of Rosacea and Encourages Healthcare Professionals To Look ‘Beyond the Visible’
